Ann: Preliminary Final Report, page-7

First post on BOT , and I know has been mentioned/posted before, but the reiteration of the following potential revenue maker below would be icing on the top of any successful treatments!

Business development and strategic partnerships (PermetrexTM)

During  the  year,  Botanix  continued  to  work  collaboratively  with  multiple  partners  to  utilise  the  PermetrexTM delivery technology to formulate new drugs in development.  These collaborations involve undertaking  early  stage  paid  formulation  work  for  select  collaborators,  which  will  be  followed  by  human  skin  testing  and  product characterisation  work. This  work  helps  to  offset  the  Company’s  operational  costs  and  may  also  translate  into  future  licensing  opportunities  for  the  PermetrexTMplatform,  which  may  provide  immediate  revenue  and  the  potential  for  substantial  revenues from  milestone payments and royalties, at no additional cost to Botanix